Search

Your search keyword '"Habib, Saadi A."' showing total 8 results
Start Over Author "Habib, Saadi A."
8 results on '"Habib, Saadi A."'

2. Outcomes and Conclusions from the 2022 AM Bench Measurements, Challenge Problems, Modeling Submissions, and Conference

Author

Levine, Lyle, Lane, Brandon, Becker, Chandler, Belak, James, Carson, Robert, Deisenroth, David, Glaessgen, Edward, Gnaupel-Herold, Thomas, Gorelik, Michael, Greene, Gretchen, Habib, Saadi, Higgins, Callie, Hill, Michael, Hrabe, Nik, Killgore, Jason, Kim, Jai Won, Lemson, Gerard, Migler, Kalman, Moylan, Shawn, Pagan, Darren, Phan, Thien, Praniewicz, Maxwell, Rowenhorst, David, Schwalbach, Edwin, Seppala, Jonathan, Simonds, Brian, Stoudt, Mark, Weaver, Jordan, Yeung, Ho, and Zhang, Fan

Published
2024
Full Text
View/download PDF

8. Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study

Author

Beverly Winikoff, Leila Maazoun, Selma Hajri, Habib Saadi, Jennifer Blum, Nabiha Gueddana, Hela Chelli, and Rasha Dabash

Subjects
Adult, medicine.medical_specialty, Tunisia, Office Visits, medicine.medical_treatment, Administration, Oral, Developing country, Abortion, Health Services Accessibility, Patient satisfaction, Pregnancy, medicine, Humans, Misoprostol, Abortifacient, Gynecology, Abortifacient Agents, Nonsteroidal, business.industry, Obstetrics and Gynecology, Abortion, Induced, Mifepristone, medicine.disease, Medical abortion, Reproductive Medicine, Patient Satisfaction, Family medicine, Female, Safety, business, medicine.drug
Abstract

From November 2000 to July 2001, 321 consenting women were enrolled at four sites across the country in an effort to demonstrate that mifepristone medical abortion could safely be used by providers throughout Tunisia. Women who met the study's inclusion criteria were given 200 mg oral mifepristone and offered the choice of taking 400 microg oral misoprostol 2 days later either at home or at the clinic. At follow-up, women were examined to determine completed abortion status and surveyed to gauge their satisfaction with the method. Ninety-six percent of women had a successful abortion using this method. Women expressed a strong preference for home use of misoprostol, indicating that it is more confidential (34%), easier (28%) and requires fewer clinic visits (28%). The high rate of success, demonstrated safety and acceptability of the method in new facilities and with new providers suggests that medical abortion can be safely expanded to new settings with reasonable levels of training and supervision.

Published
2004
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results